glutathione level mda mb 468 Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics | Cancer Cell International Frontiers | Formononetin triggers ferroptosis
Frontiers Formononetin triggers ferroptosis in triple negative breast cancer cells by regulating the mTORC1 SREBP1 SCD1 pathway mir5500_01.jpg Breast cancer cells that preferentially metastasize to lung or bone are more glycolytic, synthesize serine at greater rates, and consume less ATP and NADPH than parent MDA MB 231 cells Cancer & Metabolism Frontiers Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential
Pay in 4 interest-free payments of $6.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20



